| 
                                  PF-32201                               | 
                              
                                  VITAMINAS NEUROTROPAS Neoethicals 25000 mcg Solucion Inyectable                               | 
                              
                                  2029-05-28                               | 
                              
                                                                 | 
                                                             
                                Neoethicals                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Neoethicals                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-32575                               | 
                              
                                  LIDOCAINA  Caplin 2 % Solucion Inyectable                               | 
                              
                                  2024-05-05                               | 
                              
                                                                 | 
                                                             
                                Caplin Point Laboratories Ltd.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Neoethicals                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-55035                               | 
                              
                                  CEFOTAXIMA Caplin 1 g  Polvo para uso parenteral                               | 
                              
                                  2023-03-14                               | 
                              
                                                                 | 
                                                             
                                Caplin Point Laboratories Limited                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Neoethicals                               | 
							                                
                                Servi-Logistics                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-34940                               | 
                              
                                  AMPICILINA Caplin 500 mg cápsulas                               | 
                              
                                  2025-03-03                               | 
                              
                                                                 | 
                                                             
                                Neoethicals                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Neoethicals                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-36622                               | 
                              
                                  AMPICILINA Caplin 1 g Polvo para solución inyectable                               | 
                              
                                  2025-12-06                               | 
                              
                                                                 | 
                                                             
                                Caplin Point Laboratories Ltd.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Neoethicals                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-41315                               | 
                              
                                  CEFTRIAXONA SODICA  Diga Trading 1 g Polvo liofilizado para uso parenteral                               | 
                              
                                  2018-09-08                               | 
                              
                                                                 | 
                                                             
                                Diga Trading, S.A.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Hillroy                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-44087                               | 
                              
                                  SALES DE REHIDRATACION ORAL CSPC 20.5 g Polvo para solución oral                               | 
                              
                                  2020-01-20                               | 
                              
                                                                 | 
                                                             
                                CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Lebec                               | 
							                                
                                PSI Guatemala                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-44207                               | 
                              
                                  ISOSORBIDE MONONITRATO Cspc 20 mg capsulas                               | 
                              
                                  2015-02-24                               | 
                              
                                                                 | 
                                                             
                                CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Diagnopharm,  S.A.                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-44896                               | 
                              
                                  PROPAFENONA CLORHIDRATO CSPC 150 mg Tabletas                               | 
                              
                                  2015-07-23                               | 
                              
                                                                 | 
                                                             
                                CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Diagnopharm,  S.A.                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |                               
                          
                                                
                              | 
                                  PF-44431                               | 
                              
                                  CEFALOTINA CSPC 1.0 g Liofilizado para uso parenteral                               | 
                              
                                  2015-04-08                               | 
                              
                                                                 | 
                                                             
                                CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.                               |                               
                                                            
                                República de China                              
                               | 
                                                            
                                Diagnopharm,  S.A.                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               | 
							                                
                                                               |